Lilly Buys Psychedelics Maker Atai Beckley for $2.8B
Eli Lilly unveils a landmark $2.8 billion cash deal to acquire Atai Beckley, aiming to push a DMT-like therapy for tr...
Choosing the right credit card can unlock amazing bonuses. Explore the options that offer the best rewards for your spending habits.
24,052 articlesEli Lilly unveils a landmark $2.8 billion cash deal to acquire Atai Beckley, aiming to push a DMT-like therapy for tr...
A collaboration blends Star Wars icons with NFL teams, sparking fan excitement and new budgeting needs. This guide br...
Institutional landlords are stepping up the sale of single-family rentals as the ROAD Act takes effect. Early data sh...
Rate expanded its team by hiring seven former Movement Mortgage loan officers in December 2025, underscoring a broade...
As fuel costs climb, airline stocks stumble and investors reassess 2026 earnings prospects. This piece breaks down wh...
Bitcoin reserves on centralized venues remain a sizable market feature even after FTX. Analysts say liquidity, lendin...
A viral essay about a future ‘ghost GDP’ scenario is forcing CEOs to rethink automation budgets as profits soar and c...
A fresh look at how large holders deploy a bitcoin giant strategy and why Coinbase finds itself among the most shorte...
A major partnership reshapes Novo Nordisk's growth trajectory. This deep dive explains what the Vivtex deal means for...
A confidential settlement in Maryland ends a high-profile dispute over HeLa cell patents and profits, signaling a new...
A debt-free battery metals explorer with a large deep-sea resource aims for 2027 production, as regulators weigh perm...
As Cricut reports its 2025 earnings, investors weigh growth engines, profitability, and strategic bets. This guide br...